Last Updated: 17 Sep 2024
Executive Summary
Maxeon Solar Technologies Ltd. (MAXN) is a solar panel manufacturer and seller headquartered in Singapore. The company has a market capitalization of $119.46 million and its latest stock price is $0.08. Maxeon's financial performance has been weak in recent quarters, with negative EBITDA, EPS, and profit margins. Analysts have a "Hold" rating on the stock, with a target price of $2.36.
Company Overview
Maxeon Solar Technologies Ltd. designs, manufactures, markets, and sells solar panels and related solar system components worldwide. The company's products are used in residential, commercial, and industrial applications. Maxeon has a global presence, with operations in the United States, Europe, Asia, and Australia.
Fundamental Analysis
Maxeon's financial performance has been weak in recent quarters. The company reported negative EBITDA of $168.66 million and EPS of -$7.73 in the latest quarter. Maxeon's profit margins are also negative, with a gross profit margin of -0.439% and an operating margin of -0.367%. The company's revenue growth has also been weak, with quarterly revenue growth of -0.471% in the latest quarter.
Technical Analysis
Maxeon's stock price has been in a downtrend in recent months. The stock is currently trading below its 50-day and 200-day moving averages. The stock's relative strength index (RSI) is also below 30, indicating that the stock is oversold.
Short Term Outlook
The short-term outlook for Maxeon is negative. The company's financial performance is weak and its stock price is in a downtrend. The stock is also oversold, which could lead to further declines in the near term.
Long Term Outlook
The long-term outlook for Maxeon is uncertain. The company's financial performance has been weak in recent quarters, but the solar industry is expected to grow in the long term. If Maxeon can improve its financial performance, it could benefit from the growth of the solar industry.
Analyst Recommendations
Analysts have a "Hold" rating on Maxeon, with a target price of $2.36. This target price is significantly higher than the current stock price, which suggests that analysts believe that the stock is undervalued.
